Enhanced benefit from adjuvant systemic chemotherapy in breast cancer patients classified high-risk according to uPA and PAI-1 (n = 3 424). - Harbeck,N.; Kates,R.E.; Look,M.P.; Meijer-van Gelder,M.E.; Klijn,J.GM.; Jänicke,F.; Krüger,A.; Kiechle,M.; Schmitt,M.; Foekens,J.A. (Cancer Res, 2002)